Compelling epidemiological evidence indicates that alterations of mitochondrial DNA, including mutations and abnormal content of mitochondrial DNA (mtDNA), are associated with the initiation and development of cardiovascular disease. This study was undertaken to investigate whether mtDNA copy number in peripheral blood cells could be used as a risk predictor for coronary heart disease.
Study Type
OBSERVATIONAL
Enrollment
400
Xijing Hospital
Xi'an, Shaanxi, China
Relative copy number of mitochondrial DNA
The ratio of mitochondrial DNA copy number to hemoglobin copy number was calculated for each sample from standard curves. After that, the ratio for each sample was normalized to a calibrator DNA in order to standardize between different runs, and then defined as the measurement of relative mtDNA copy number.Relative copy number of Mitochondrial DNA were measured in CHD patients in comparison to control group.
Time frame: From date of percutaneous coronary intervention until the date of discharging from hospital, assessed up to 5 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.